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Objective. We studied the clinicopathological parameters of adenocarcinoma arising from endocervix (ECA) and from
endometrium (EMA) based on the expression of P16ink4a, P21waf1, and p27Kip1 proteins. Study Design. Immunohistochemistry
was done on sections of conﬁrmed ECA and EMA from hysterectomy specimens which have had no prior chemother-
apy/radiotherapy. Results. There were 40 ECAs and 92 EMAs. The mean age of ECA was 49.82 (SD 10.29); the youngest was
30 years old and the oldest 75 years old. The mean age of EMA was 54.45 (SD 10.92); the youngest was 30 years old and the oldest
was 82 years old. For ECA, the size of the tumour is signiﬁcantly associated with age and with depth of inﬁltration. FIGO stage
is associated with histological grade. p21WAF1 expression is signiﬁcantly associated with inﬁltration of the corpus and lymph
node metastasis. p27Kip1 expression is signiﬁcantly associated with lymph node invasion. The presence of lymph node metastasis
is strongly associated when p16INK4a and p27Kip1 expressions are analyzed in combination. For EMA, p16INK4a expression is
associated with histologic grade. Conclusion. Our study shows that we could use these cell cycle markers as predictors for more
aggressive subsets of adenocarcinoma of the cervix and endometrium.
1.Introduction
The trend of adenocarcinoma of the cervix (ECA) is increas-
ing[1–3]particularlyamongyoungerwomen[4].Adenocar-
cinoma of the endometrium on the other hand aﬀect older
women, in the ﬁfth to six decade [5]. In routine clinical prac-
tice, the presentation of these two cancers often overlap [6]
and each requires diﬀerent management [7]. ECA has more
risk of recurrence [8] than endometrial adenocarcinoma. In
Malaysia, adenocarcinoma of the cervix accounts for 5–15%
of the total cervical cancers and the trend is also increasing
[9]. The histological appearance of these two cancers under
routine H/E staining is almost similar in many instances. In a
study on fractional curettage specimens from ﬁfteen women
whohadtumoursintheendocervicalandendometrialspeci-
mens,only34.1%werediagnosedasendometrialcarcinomas
[10]. Carcinoembryonic antigen (CEA), estrogen receptor
(ER), vimentin, and a panel of histochemical stains [11]a r e
routinely used to diﬀerentiate these two cancers [12, 13].
Routine IHC studies may not be helpful for synchronous
endometrial and endocervical tumors [14]. In such, clonality
studiesusingrobustmoleculartechniquesmayhelpdiagnose
cases in which conventional imunohistochemical studies are
not helpful [14].
p16INK4A is a molecular biomarker that consistently
discriminates uterine cervix adenocarcinoma from endome-
trial adenocarcinoma [15]. It is a cell cycle regulatory tum-
our suppressor gene that has intimate interplay with the
retinoblastomagene[16].p16INK4Acoulddiﬀerentiatesim-
ilar skin conditions: actinic keratosis from Bowens disease
of which diﬀerentiating them before deﬁnitive treatment is
important as each has diﬀerent management [16]. p21WAF1
is a cyclin-dependent kinase inhibitor which acts as both a
sensor and an eﬀector of multiple antiproliferative signals2 Infectious Diseases in Obstetrics and Gynecology
[17]. p27Kip1 is a negative regulator of the G1 phase of the
cell cycle [18]. Attempts at diﬀerentiating the clinicopatho-
logical parameters of adenocarcinoma of the cervix from en-
dometrium have been done by a number of researchers us-
ing immunohistochemical stains [13, 14] and molecular
techniques such as Western blotting [19]a n dP C R[ 20, 21].
Among the parameters studied was presence of estrogen re-
ceptor status [19, 22].
We studied the clinical parameters of adenocarcinomas
arisingfromendocervixbasedontheexpressionofP16ink4a,
P21waf1, and p27Kip1 proteins and whether the presence/
absence of such protein expression correlate with clinical
presentations/behaviour of these cancers.
2.Methodology
This is a retrospective study on archived tissue blocks of his-
tologically conﬁrmed adenocarcinoma of the cervix and en-
dometrium diagnosed from 2005 to 2008. The samples were
hysterectomy specimens with or without removal of ovaries
and fallopian tubes. Biopsies (either colposcopic or by cu-
rettage) were excluded. Specimens from patients who have
hadchemotherapyorradiotherapybeforehysterectomywere
excluded. These samples were taken from two public hos-
pitals located in two diﬀerent localities: Hospital Universiti
Sains Malaysia (HUSM) (north-eastern region) and Hospital
Sultanah Bahiyah (HSB) (north-western region of Malaysia).
The demography and the clinical details were obtained
from the case folders. The histological diagnoses of ECA and
EMAwerecategorizedaccordingtothemainhistologicalfea-
ture as endocervical NOS, adenosquamous, endometrioid,
serous, and clear cell. The cancers are called “mixed” when
the histological ﬁndings show more than one histologi-
cal patterns. Immunohistochemistry staining was done on
4 micron thickness sections from paraﬃn blocks using
the standard immunohistochemical staining technique.
p16INK4a, P21WAF1, and P27Kip1 primary antibodies were
at 1:100 dilutions. Positive controls were squamous cell car-
cinomaforp16INK4a,colonicadenocarcinomaforp21KIP1,
and normal prostatic tissue for p27Kip1 tissue as per sugges-
tion by manufacturers of these antibodies. The association
was determined using multiple logistic regression tests. The
results were analysed using SPSS version 16, and the level of
conﬁdence (P value) was set at 0.05.
The study was approved by the Research Ethics Commit-
tee of Universiti Sains Malaysia.
3. Results
There were 40 adenocarcinomas (ECAs) of the endocervix
and 92 adenocarcinomas of the endometrium (EMAs). The
median age for adenocarcinoma of the cervix was 48.5 years,
and the mean age was 49.82 (SD 10.3). The youngest patient
was 30 years old and the oldest 75 year old. The median age
for adenocarcinoma of the endometrium was 55.0 years and
the mean age was 54.45 (SD 10.9). The youngest patient was
30 years old and the oldest 82 years old. For adenocarcinoma
of the cervix, there were 74% Malays, 18% Chinese, 8%
Table 1: Summary of the clinicopathological parameters in adeno-
carcinoma of the cervix (ECA) and adenocarcinoma of the endo-
metrium (EMA).
Variables of ECA
Frequency
(%) of
ECA
Variables of EMA
Frequency
(%) of
EMA
Age (years) Age (years)
<35 3 (7.5) <50 28 (30.4)
35–54 22 (55.0) 50–60 35 (38.0)
≥55 15 (37.5) >60 29 (31.5)
FIGO stage FIGO stage
I 27 (57.5) I 50 (54.3)
ll 7 (17.5) II 13 (14.1)
lll 5 ((12.5) lll 13 (14.1)
IV 5 (12.5) lV 16 (17.4)
Histology tumor
diﬀerentiation
Myometrial
invasion
Well/moderate 25 (62.5) < 1/2 45 (48.9)
Poor and Special type 15 (37.5) > 1/2 47 (51.1)
Inﬁltration depth Histologic grade
Inner 2/3 13 (32.5) G1 39 (42.4)
Outer 1/3 or through 27 (67.5) G2 23 (25.0)
G3 30 (32.6)
Tumor length Postmenopausal
status
<20mm 11 (32.5) Yes 54 (58.7)
>20mm 29 (67.5) No 38 (41.3)
Tumor thickness
<5mm 4 (10.0)
>5mm 36 (90.0)
Inﬁltration to corpus
Yes 17 (42.5)
No 23 (57.5)
Vascular invasion
Yes 20 (50.0)
No 20 (50.0)
Lymph node invasion
Yes 12 (30.0)
No 28 (70.0)
Histologic type: Histologic type:
Endocervical NOS 25 (62.5) Endometrioid 75 (81.5)
Adenosquamous 6 (15.0) Adenosquamous 4 (4.4)
Endometrioid 5 (12.5) Clear cell 5 (5.4)
Serous 1 (2.5) Serous 5 (5.4)
“Mixed” 2 (5.0) “Mixed” 3 (3.3)
Siamese, and no Indian patients while for endometrial
carcinoma,therewere79%Malays,11%Chinese,9%Indian,
and 1% Siamese ethnic group.
T h em o s tc o m m o nh i s t o l o g i c a lt y p eo fa d e n o c a r c i -
noma of the cervix was mucinous type: 62.5% (25/40),
and the commonest histological subtype of endometrialInfectious Diseases in Obstetrics and Gynecology 3
Table 2: Interrelationship∗ between clinicopathologic parameters in patients with adenocarcinoma of the cervix (ECA).
Age
group
(P value)
Ethnic
(P value)
Diagnosis
(P value)
Histo
grade
(P value)
FIGO
stage
(P value)
Inﬁltration
depth
(P value)
Tumour
size
(diameter)
(P value)
Tumor
thickness
(P value)
Corpus
inﬁltra-
tion
(P value)
Vascular
invasion
(P value)
LN
invasion
(P value)
Age group — 0.140 0.377 0.372 0.582 0.392 0.006 0.364 0.301 0.165 0.056
Ethnic — 0.090 0.850 0.206 0.559 0.838 0.224 0.858 0.140 0.017
Histologic type — <0.0001 0.572 0.191 0.411 0.586 0.804 0.744 0.722
Histologic grade — 0.090 0.542 0.120 0.586 0.680 0.102 0.012
FIGO stage — 0.330 0.152 1.000 0.042 0.003 <0.0001
Inﬁltration depth — 0.010 0.056 0.085 0.018 0.507
Tumor length — 0.025 0.230 0.013 0.076
Tumor thickness — 0.749 0.292 0.818
Corpus inﬁltration — 0.337 0.043
Vascular invasion — 0.038
LN invasion —
∗Calculated using Chi-square.
Table 3: Interrelationship∗ between clinicopathological parameters in patients with adenocarcinoma of endometrium (EMA).
Age group
(P value)
Menopausal
status
(P value)
Ethnic
(P value)
Diagnosis
(P value)
Histology
grade
(P value)
Myometrial
invasion
(P value)
FIGO stage
(P value)
Age group — <0.0001 0.139 0.178 0.175 0.101 0.343
Meno status — — 0.194 0.270 0.641 0.062 0.260
Ethnic — — — 0.825 0.703 0.248 0.026
Histologic type — — — — <0.0001 0.213 0.081
H i s t o l o g i c g r a d e —— ——— 0 . 0 6 0 <0.0001
M y o m e t r i a l i n v a s i o n —— ———— <0.0001
F I G O s t a g e —— —————
∗Calculated using Chi-square.
adenocarcinoma was endometrioid type (75/92). Majority of
the patients were in FIGO stage I (ECA 57.5%, EMA 54.3%).
The summary of the clinicopathological ﬁndings of the 132
cancers is in Table 1.
The interrelationship between the various clinicopatho-
logical correlations is as shown in Table 2 for ECA and Table
3 for EMA. For adenocarcinoma of the cervix, the grade was
signiﬁcantly associated with histologic type and with lymph
node.Theageofthepatientswassigniﬁcantlyassociatedwith
the size of the tumor. The tumor size is also associated with
the depth of inﬁltration. FIGO stage is strongly associated
with vascular and lymph node invasion (Table 2). For ad-
enocarcinoma of the endometrium, FIGO stage is associated
with histological grade and expectedly with myometrial
invasion (Table 3).
For adenocarcinoma of the cervix, none of the clin-
icopathological parameters is signiﬁcantly associated with
p16INK4a expression (Table 4) including the histologic sub-
types. p21WAF1 expression (Table 5) is signiﬁcantly associ-
ated with inﬁltration of the corpus (P = 0.043) and lymph
node metastasis (P = 0.071), and p27Kip1 expression (Table
6) is signiﬁcantly associated with lymph node invasion (P =
0.030). The presence of lymph node metastasis is strongly
associated (P = 0.013) when p16INK4a and p27Kip1 expres-
sions are analyzed in combination.
For adenocarcinoma of the endometrium, p16INK4a
expression (Table 7) is associated with histologic grade (P =
0.014) but not the histologic type (P = 0.888). p21WAF1
and p27Kip1 did not show signiﬁcant associations with clin-
icopathologic parameters (P>0.05).
4. Discussion
Adenocarcinoma arising from the cervix and the endome-
trium in our series shows overlapping clinicopathological
presentations. The youngest patients for both cancers were
30 years of age though the mean age of endocervical adeno-
carcinoma is about ﬁve years younger. There was a number
of adenocarcinomas of the cervix which was in the mean
age of adenocarcinoma of endometrium. These two cancers
also have similar ethnic distribution. The ethnic distribution
of our cases is comparable with the background population
implying fair representation of the sampling population.
They are more seen among the ethnic Malay than other eth-
nic groups in this series depicting the ethnic distributions of
the community served by the two hospitals.4 Infectious Diseases in Obstetrics and Gynecology
Table 4: Associations between p16INK4a expression and clinico-
pathologic parameter for endocervical adenocarcinoma.
Characteristics No. of
patients
Positive,
n (%)
(n = 32)
Negative,
n (%)
(n = 8)
P value
Age (years)
<35 3 2 (66.7) 1 (33.3)
0.256 35–54 22 16 (72.7) 6 (27.3)
≥55 15 14 (93.3) 1 (6.7)
FIGO stage
I-II 30 24 (80.0) 6 (20.0) 1.000
III-IV 10 8 (80.0) 2 (20.0)
Histology tumor
diﬀerentiation
Well/moderate 25 18 (72.0) 7 (28.0) 0.102
Poor 15 14 (93.3) 1 (6.7)
Inﬁltration depth
Inner 2/3 13 9 (69.2) 4 (30.8) 0.237
Outer 1/3 or through 27 23 (85.2) 4 (14.8)
Tumor size ([diameter)
<20mm 11 8 (72.7) 3 (27.3) 0.479
>20mm 29 24 (82.8) 5 (17.2)
Tumor thickness
<5mm 4 3 (75.0) 1 (25.0) 0.792
>5mm 36 29 (80.6) 7 (19.4)
Inﬁltration to corpus
Yes 17 13 (76.5) 4 (23.5) 0.631
No 23 19 (82.6) 4 (17.4)
Vascular invasion
Yes 20 17 (85.0) 3 (15.0) 0.429
No 20 15 (75.0) 5 (25.0)
Lymph node invasion
Yes 12 8 ( 66.7) 4 (33.3) 0.168
No 28 24 (85.7) 4 (14.3)
Histologic type
Endocervical 25 20 (80.0) 5 (20.0) 1.000
Non endocervical 15 12 (80.0) 3 (20.0)
We noted that certain clinicopathological parameters
were signiﬁcantly associated with other parameters within
thesamecancer.Foradenocarcinomaofthecervix,theageof
the patients was signiﬁcantly associated with tumor size and
with depth of inﬁltration. The histologic grade was strong-
ly associated with presence of lymph node metastasis. FIGO
staging was strongly associated with presence of corpus in-
ﬁltration, vascular invasion, and lymph node metastasis. For
adenocarcinomaofendometrium,theageofthepatientswas
associated with menopausal status, FIGO staging with histo-
logicalgradingofthecancer,andpresence/absenceofmyom-
etrial invasion.
When these clinicopathological parameters were tested
against the expression of the three cell cycle markers, none
of the clinicopathological parameters of adenocarcinoma of
Table 5: Associations between P21waf1 expression and clinico-
pathologic parameter for adenocarcinoma of the cervix.
Characteristics No. of
patients
Positive,
n (%)
(n = 28)
Negative,
n (%)
(n = 12)
P value
Age (years)
<35 3 2 (66.7) 1(33.3)
0.937 35–54 22 15 (68.1) 7 (31.8)
≥55 15 11 (73.3) 4 (33.7)
FIGO stage
I-II 30 23 (76.7) 7 (23.3) 0.111
III-IV 10 5 (50.0) 5 (50.0)
Histology tumor
diﬀerentiation
Well/moderate 25 16 (64.0) 9 (36.0) 0.285
Poor 15 12 (80.0) 3 (20.0)
Inﬁltration depth
Inner 2/3 13 10 (76.9) 3 (23.1) 0.507
Outer 1/3 or through 27 18 (66.7) 9 (33.3)
Tumor length
<20mm 11 7 (63.6) 4 (36.4) 0.589
>20mm 29 21 (72.4) 8 (27.6)
Tumor thickness
<5mm 4 1 (25.0) 3 (75.0) 0.101
>5mm 36 27 (75.0) 9 (25.0)
Inﬁltration to corpus
Yes 17 9 (52.9) 8 (47.1) 0.043
No 23 19 (82.6) 4 (17.4)
Vascular invasion
Yes 20 15 (75.0) 5 (25.0) 0.490
No 20 13 (65.0) 7 (35.0)
Lymph node invasion
Yes 12 6 (50.0) 6 (50.0) 0.071
No 28 22 (78.6) 6 (21.4)
Histologic type
Endocervical 25 17 (68.0) 8 (32.0) 0.722
Non endocervical 15 11 (73.3) 4 (26.7)
the cervix including the histologic subtypes had signiﬁ-
cant association with p16INK4a expression alone. However,
when p16INK4a expression and p27Kip1 expressions were
analyzed in combination, there were strong associations
with presence/absence of lymph node metastasis. p21WAF1
expression alone is signiﬁcantly associated with inﬁltration
of the corpus and lymph node metastasis. Lymph node
involvement was also signiﬁcantly associated with p27Kip1
expression. For adenocarcinoma of endometrium, only
P16INK4a expression had strong association with the his-
tologic grade. p21WAF1 and p27Kip1 expressions were not
signiﬁcantly associated with any clinicopathological parame-
ters.Ourstudyshowsthatwecouldusethesecellcyclemark-
ersaspredictorsformoreaggressivesubsetsofadenocarcino-
mas of the cervix and endometrium.Infectious Diseases in Obstetrics and Gynecology 5
Table 6: Associations between p27Kip1 expression and clinico-
pathologic parameter for endocervical adenocarcinoma.
Characteristics No. of
patients
Positive,
n (%)
(n = 17)
Negative,
n (%)
(n = 23)
P value
Age (years)
<35 3 2 (66.7) 1 (33.3)
0.292 35–54 22 7 (31.8) 15 (68.2)
≥55 15 8 (53.3) 7 (46.7)
FIGO stage
I-II 30 15 (50.0) 15 (50.0) 0.097
III-IV 10 2 (20.0) 8 (80.0)
Histology tumor
diﬀerentiation
Well/moderate 25 11 (44.0) 14 (56.0) 0.804
Poor 15 6 (40.0) 9 (60.0)
Inﬁltration depth
Inner 2/3 13 5 (38.5) 8 (61.5) 0.720
Outer 1/3 or through 27 12 (44.4) 15 (55.6)
Tumor length
<20mm 11 5 (45.5) 6 (54.5) 0.818
>20mm 29 12 (41.4) 17 (58.6)
Tumor thickness
<5mm 4 1 (25.0) 3 (75.0) 0.395
>5mm 36 16 (44.4) 20 (55.6)
Inﬁltration to corpus
Yes 17 6 (35.3) 11 (64.7) 0.428
No 23 11 (47.8) 12 (52.2)
Vascular invasion
Yes 20 7 (35.0) 13 (65.0) 0.337
No 20 10 (50.0) 10 (50.0)
Lymph node invasion
Yes 12 2 (16.7) 10 (83.3) 0.030
No 28 15 (53.6) 13 (46.4)
Histologic type
Endocervical 25 9 (36.0) 16 (64.0) 0.283
Non endocervical 15 8 (53.3) 7 (46.7)
There are a number of studies which have utilized the use
of cell cycle regulatory genes such as P16INK4a, p21WAF1,
and p27Kip1 in predicting the behavior of certain cancers
such as malignant astrocytomas [23], oral squamous cell
carcinomas [24], vulval carcinomas [25], and primary large-
cell neuroendocrine carcinoma of the parotid gland [26].
In the latter, markedly reduced expressions of p21Waf1 and
p27Kip1werenotedinthesalivaryglandcancercellsindicat-
ing highly aggressive biologic behavior [26]. Methylation of
p16INK4a was seen to be correlated with gender and tumor
size (P = 0.005 and P = 0.035, resp.) in colorectal carcinoma
(CRC) and could be used as a marker of poor prognosis in
CRC [27]. In 224 vulvar squamous cell carcinomas stained
withp16, p21, and p27, Knopp et al.,noted ahigh expression
of p16 as indicator of a better prognosis in the multivariate
Table 7: Associations between P16INK4a expression and clinico-
pathologic parameter for endometrial adenocarcinoma.
Characteristics No.
patients
Positive,
n (%)
(n = 23)
Negative,
n (%)
(n = 69)
P value
Age (years)
<50 28 5 (17.9) 23 (82.1)
0.148 50–60 35 7 ( 20.0) 28 (80.0)
>60 29 11 (38.0) 18 (62.0)
FIGO stage
I 50 12 (24.0) 38 (76.0) 0.809
II–IV 42 11 (26.2) 31 (73.8)
Myometrial invasion
< 1/2 45 9 (20.0) 36 (80.0) 0.278
> 1/2 47 14 (29.8) 33 (70.2)
Histologic grade
G1-G2 62 11 (17.7) 51 (82.2) 0.014
G3 30 12 (40.0) 18 (60.0)
Postmenopausal status
Yes 54 16 (29.6) 38 (70.4) 0.222
No 38 7 (18.4) 31 (81.6)
Histologic type
Endometrioid 75 16 (21.3) 59 (78.7) 0.888
Non endometrioid 17 7 (41.2) 10 (58.8)
analysis (RR = 0.5, 95% CI = 0.2–1.0) and less risk of devel-
oping lymph node metastasis (OR = 0.3, 95% CI = 0.2–0.7)
[25].Theyalsonotedthatahighlevelofp21wassigniﬁcantly
associated with shorter survival in patients staged FIGO I
and II (RR = 3.4, 95% CI = 1.3–9.3). We could not ﬁnd any
published literature on utilizing the use of these markers on
adenocarcinoma of the cervix and endometrium
In conclusion, for adenocarcinoma of the cervix,
p21WAF1 expression is signiﬁcantly associated with inﬁl-
tration of the corpus and lymph node metastasis. p27Kip1
expression is signiﬁcantly associated with lymph node inva-
sion. The presence of lymph node metastasis is strongly asso-
ciatedwhenp16INK4aandp27Kip1expressionsareanalyzed
in combination. For adenocarcinoma of the endometrium,
p16INK4a expression is associated with histologic grade but
not histologic type. Our study shows that we could use these
cell cycle markers as predictors for more aggressive subsets of
adenocarcinoma of the cervix and endometrium.
Acknowledgment
The authors would like to acknowledge the Universiti Sains
Malaysia for providing research grant (Account # 1001/
PSKBP/812024) to do this study.
References
[1] S. K. Kjaer and L. A. Brinton, “Adenocarcinomas of the uter-
ine cervix: the epidemiology of an increasing problem,” Epide-
miologic Reviews, vol. 15, no. 2, pp. 486–498, 1993.6 Infectious Diseases in Obstetrics and Gynecology
[ 2 ]H .O .S m i t h ,M .F .T i ﬀany, C. R. Qualls, and C. R. Key, “The
rising incidence of adenocarcinoma relative to squamous cell
carcinoma of the uterine cervix in the United States—a 24-
year population-based study,” Gynecologic Oncology, vol. 78,
no. 2, pp. 97–105, 2000.
[3] F. Bray, B. Carstensen, H. Møller et al., “Incidence trends
of adenocarcinoma of the cervix in 13 European countries,”
Cancer Epidemiology Biomarkers and Prevention,v o l .1 4 ,n o .9 ,
pp. 2191–2199, 2005.
[4] F. Parazzini and C. La Vecchia, “Epidemiology of adenocarci-
noma of the cervix,” Gynecologic Oncology, vol. 39, no. 1, pp.
40–46, 1990.
[5] J .M.Elwood,P .Cole,K.J .Rothman,andS.D .K aplan,“Epide-
miologyofendometrialcancer,”JournaloftheNationalCancer
Institute, vol. 59, no. 4, pp. 1055–1060, 1977.
[6] K. Garg, K. Shih, R. Barakat, Q. Zhou, A. Iasonos, and R.
A. Soslow, “Endometrial carcinomas in women aged 40 years
and younger: tumors associated with loss of DNA mismatch
repair proteins comprise a distinct clinicopathologic subset,”
American Journal of Surgical Pathology, vol. 33, no. 12, pp.
1869–1877, 2009.
[7] L. T. Gien, M. C. Beauchemin, and G. Thomas, “Adenocar-
cinoma: a unique cervical cancer,” Gynecologic Oncology, vol.
116, no. 1, pp. 140–146, 2010.
[8] E. H. Tay, M. L. Yeap, and T. H. Ho, “A 5-year review of FIGO
stage IB cervical cancer in an Asian population,” Singapore
Medical Journal, vol. 38, no. 12, pp. 520–524, 1997.
[9] P. L. Cheah and L. M. Looi, “Carcinoma of the uterine cervix:
a review of its pathology and commentary on the problem in
Malaysians,” Malaysian Journal of Pathology, vol. 21, no. 1, pp.
1–15, 1999.
[10] P. Tantbirojn, S. Triratanachat, P. Trivijitsilp, and S. Niruthis-
ard, “Comparison between adenocarcinoma in both endocer-
vicalandendometrialspecimensfromfractionalcurettageand
pathologic ﬁndings in subsequent hysterectomy specimens,”
Journal of the Medical Association of Thailand, vol. 91, no. 9,
pp. 1313–1317, 2008.
[11] L. Nieuwenhuizen, M. K. Khalil, N. Venkatesh, and N. H.
Othman, “Endometrial and endocervical secretion: the search
for histochemical diﬀerentiation,” Analytical and Quantitative
Cytology and Histology, vol. 28, no. 2, pp. 87–96, 2006.
[12] S. Kamoi, M. I. AlJuboury, M. R. Akin, and S. G. Silverberg,
“Immunohistochemical staining in the distinction between
primary endometrial and endocervical adenocarcinomas: an-
other viewpoint,” International Journal of Gynecological Pa-
thology, vol. 21, no. 3, pp. 217–223, 2002.
[13] D. H. Castrillon, K. R. Lee, and M. R. Nucci, “Distinction be-
tween endometrial and endocervical adenocarcinoma: an im-
munohistochemicalstudy,”InternationalJournalofGynecolog-
ical Pathology, vol. 21, no. 1, pp. 4–10, 2002.
[14] L. Jiang, A. Malpica, M. T. Deavers et al., “Endometrial endo-
metrioid adenocarcinoma of the uterine corpus involving the
cervix:somecasesprobablyrepresentindependentprimaries,”
International Journal of Gynecological Pathology, vol. 29, no. 2,
pp. 146–156, 2010.
[15] N. Missaoui, S. Hmissa, L. Frappart et al., “p16INK4A over-
expression and HPV infection in uterine cervix adenocarci-
noma,” Virchows Archiv, vol. 448, no. 5, pp. 597–603, 2006.
[16] C. J. Sherr, “Cancer cell cycles,” Science, vol. 274, no. 5293, pp.
1672–1677, 1996.
[17] T. Abbas and A. Dutta, “P21 in cancer: intricate networks and
multiple activities,” Nature Reviews Cancer,v o l .9 ,n o .6 ,p p .
400–414, 2009.
[18] S. Huang, C. S. Chen, and D. E. Ingber, “Control of cyclin
D1, p27(Kip1), and cell cycle progression in human capillary
endothelial cells by cell shape and cytoskeletal tension,”
Molecular Biology of the Cell, vol. 9, no. 11, pp. 3179–3193,
1998.
[19] D. R. Ciocca, L. A. Puy, and L. C. Fasoli, “Study of estrogen
receptor, progesterone receptor, and the estrogen-regulated
M(r) 24,000 protein in patients with carcinomas of the
endometrium and cervix,” Cancer Research, vol. 49, no. 15, pp.
4298–4304, 1989.
[20] K. I. Pappa, M. Choleza, S. Markaki et al., “Consistent absence
of BRAF mutations in cervical and endometrial cancer despite
KRAS mutation status,” Gynecologic Oncology, vol. 100, no. 3,
pp. 596–600, 2006.
[21] A. Yemelyanova, R. Vang, J. D. Seidman, P. E. Gravitt, and B.
M. Ronnett, “Endocervical adenocarcinomas with prominent
endometrial or endomyometrial involvement simulating pri-
mary endometrial carcinomas: utility of HPV DNA detection
and immunohistochemical expression of p16 and hormone
receptors to conﬁrm the cervical origin of the corpus tumor,”
American Journal of Surgical Pathology, vol. 33, no. 6, pp. 914–
924, 2009.
[22] H. Fujiwara, G. Tortolero-Luna, M. F. Mitchell, J. P. Koulos,
and T. C. Wright Jr., “Adenocarcinoma of the cervix: expres-
sion and clinical signiﬁcance of estrogen and progesterone
receptors,” Cancer, vol. 79, no. 3, pp. 505–512, 1997.
[23] T. Ohta, T. Watanabe, Y. Katayama et al., “Aberrant promoter
hypermethylation proﬁle of cell cycle regulatory genes in
malignant astrocytomas,” Oncology Reports,v o l .1 6 ,n o .5 ,p p .
957–963, 2006.
[24] E. Ishida, M. Nakamura, M. Ikuta et al., “Promotor hyperme-
thylation of p14ARF is a key alteration for progression of oral
squamous cell carcinoma,” Oral Oncology,v o l .4 1 ,n o .6 ,p p .
614–622, 2005.
[ 2 5 ]S .K n o p p ,T .B j ø r g e ,J .M .N e s l a n d ,C .T r o p ´ e, M. Scheistrøen,
andR.H olm,“ p16 INK4a andp21Waf1/Cip1 expressioncorrelates
with clinical outcome in vulvar carcinomas,” Gynecologic
Oncology, vol. 95, no. 1, pp. 37–45, 2004.
[26] T. Nagao, I. Sugano, Y. Ishida et al., “Primary large-cell neu-
roendocrine carcinoma of the parotid gland: immunohisto-
chemical and molecular analysis of two cases,” Modern Pathol-
ogy, vol. 13, no. 5, pp. 554–561, 2000.
[27] I. Miladi-Abdennadher, R. Abdelmaksoud-Damak, L. Ayadi
et al., “Aberrant methylation of hMLH1 and p16INK4a in
Tunisian patients with sporadic colorectal adenocarcinoma,”
Bioscience Reports, vol. 31, no. 4, pp. 257–264, 2011.